Table 2.
Comorbidities in LTCF Residents With COVID-19 in Reviewed Studiesa
| Comorbidity b | No. (%) |
|---|---|
| Cancer | 2 (3)12
15 (14.9)15 |
| Cardiac disease | 13 (17)12
102 (23.0)20 2 (50)18 199 (50.5)14 61 (60.4)15 12 (63)11 39 (81)9 32 (84)10 |
| Cerebrovascular accident | 5 (6.5)12
95 (24.1)14 10 (26)10 19 (40)9 |
| Cognitive impairment | 16 (21)12
28 (58)9 301 (68.0)20 32 (84)10 |
| COPD | 8 (10)12
4 (21)11 |
| Dementia | 223 (56.6)14 |
| Diabetes mellitus | 15 (19)12
92 (23.4)14 9 (24)10 32 (31.7)15 165 (37.2)20 18 (38)9 2 (50)18 11 (58)11 |
| Hypertension | 17 (22)12
68 (67.3)15 13 (68)11 309 (69.8)20 |
| Immunological | 9 (8.9)15 |
| Liver disease | 6 (5.9)15 |
| Obesity | 4 (5)12
101 (22.8)20 11 (23)9 1 (25)18 10 (26)10 31 (30.7)15 7 (37)11 |
| Pulmonary disease | 59 (15)14
9 (24)10 1 (25)18 32 (31.7)15 142 (32)20 18 (38)9 |
| Received hemodialysis | 1 (1.3)12
3 (6)9 |
| Renal disease | 3 (4)12
3 (16)11 86 (21.8)14 1 (25)18 18 (38)9 41 (40.6)15 26 (68)10 |
Note. COPD, chronic obstructive pulmonary disease.
a
Only studies that preset clinical data are listed.
b
Some comorbidity categories were consolidated.